How to Cite
Abstract
Data on the frequency of peripheral Treg cells, their functional activity, as well as their relationship to changes in characteristics of cellular immunity in patients with colorectal cancer (CRC, n=42) and healthy donors (n=34) are presented in the article. Assessment of the expression of molecular markers of lymphocytes was performed by multicolor flow cytometry. It was shown that the number of these cells is significantly increased in CRC patients (p<0,05). Probably CD4+CD25+FOXP3+ Treg cells may play a more substantial role in the periphery during the initial period of tumor formation, whereas CD8+FOXP3+ Treg cells are important in the later stages of the disease. In CRC patients, the increase of the functional activity of Treg cells (CD4+CD25+CD127lo/‘) on the expression of inhibitory molecules CTLA-4 and the marker of cell proliferation Ki-67 was observed. In patients with CRC, the frequency of peripheral Treg cells and the expression level of CTLA-4 were inversely correlated with the number of CD3+CD4+ T-helper cells.References
Жулай Г.А., олейник Е.К. регуляторные Т-клетки и канцерогенез // Иммунология. - 2013. - Т. 34. - №1. - С. 61-64.
Циммерман Я.С. Колоректальный рак: современное состояние проблемы // росс. журнал гастроэнтерологии, гепатологии, колопроктологии. - 2012. - Т. 22 №4. - С. 5-17.
Chaput N., Louafi S., Bardier A. et al. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue // Gut. - 2009. - Vol. 58. - № 4. - P 520-529.
Deng L., Zhang H., Luan Y et al. Accumulation of foxp3+ T regulatory cells in draining lymph nodes correlates with disease progression and immune suppression in colorectal cancer patients // Clin Cancer Res. - 2010. - Vol. 16. - №16. - P 4105-4112.
Elpek K.G., Lacelle С., Singh N.P, Yolcu E.S., Shirwan H. CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B cell lymphoma model // J. Immunol. - 2007. - Vol. 178. - P 6840-6848
Ling K. L., Pratap S. E., Bates G. J., Singh B. et al. Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients // Cancer Immun. - 2007. - Vol. 7. - №7
Lutgens M.W., Vleggaar F.P, Schipper M.E. et al. High frequency of early colorectal cancer in inflammatory bowel disease // Gut. - 2008. - Vol. 57. - № 9. - P. 1246-1251.
Nosho K., Baba Y, Tanaka N. et al. Tumour-in ltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review // J Pathol. - 2010. - Vol. 222. - № 4. - P 350-366.
Salama P, Phillips M., Grieu F. et al. Tumor-in ltrating FOXP3+ T regulatory cells show strongprognostic signi cance in colorectal cancer // J Clin Oncol. - 2009. - Vol. 27. - № 2. - P 186-192.
Schott A.K., Pries R., Wollenberg B. Permanent up-regulation of regulatory T-lymphocytes in patients with head and neck cancer // Int J Mol Med. - 2010. - Vol. 26. - № 1. - P. 67-75
Shevach E.M. Mechanisms of FoxP3+ T regulatory cell-mediated suppression // Immunity. - 2009. - Vol. 30. - № 5. - P. 636-645.
Vanneman M., Dranoff G. Combining immunotherapy and targeted therapies in cancer treatment // Nat Rev Cancer. - 2012. - Vol. 12. - № 4. - P 237-251
Watanabe M.A., Oda J.M., Amarante M.K., Voltarelli J.C. Regulatory T cells and breast cancer: implications for immunopathogenesis // Cancer Metastasis Rev. - 2010. -Vol. 29. - № 4. - P. 569-579.
Wicherek L., Jozwicki W., Windorbska W. et al. Analysis of Treg cell population alterations in the peripheral blood of patients treated surgically for ovarian cancer a preliminary report // Am J Reprod Immunol. - 2011. - Vol. 66. - № 5. - P 444-450.
Yang Z.Z., Ansell S.M. The role of Treg cells in the cancer immunological response // Am. J. Immunol. - 2009. -Vol. 5. - № 1. - P. 17-28.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...